Open Journal of Immunology
Vol.8 No.2(2018), Paper ID 85689, 8
pages
DOI:10.4236/oji.2018.82003
Is Neutrophil-to-Lymphocyte Ratio a Prediction Marker for Success of Immunotherapy? Preliminary Results
Noam Asna, Ornit Cohen, Ron Batash, Asaf Sigron, Tatiana Harkovski, Moshe Schaffer
Department of Oncology, Barzilai Medical Center, Ashkelon, Israel
Research Center, Barzilai Medical Center, Ashkelon, Israel
Orthopedic Department, Barzilai Medical Center, Ashkelon, Israel
Department of Oncology, Barzilai Medical Center, Ashkelon, Israel
Department of Oncology, Barzilai Medical Center, Ashkelon, Israel
Department of Oncology, Barzilai Medical Center, Ashkelon, Israel
Faculty of Medicine, Ben Gurion University of the Negev, Beer Sheva, Israel
Copyright © 2018 Noam Asna, Ornit Cohen, Ron Batash, Asaf Sigron, Tatiana Harkovski, Moshe Schaffer et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Asna, N. , Cohen, O. , Batash, R. , Sigron, A. , Harkovski, T. and Schaffer, M. (2018) Is Neutrophil-to-Lymphocyte Ratio a Prediction Marker for Success of Immunotherapy? Preliminary Results.
Open Journal of Immunology,
8, 29-35. doi:
10.4236/oji.2018.82003.